AI to diagnose lymph node spread in nasopharyngeal cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial tests whether a computer model can accurately detect if cancer has spread to lymph nodes in patients with nasopharyngeal carcinoma. It uses MRI and PET/CT scans taken before treatment to see if the AI can replace or supplement current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of nasopharyngeal carcinoma (WHO types I, II, or III).
- You must have had an MRI scan before starting any cancer treatment, which includes specific image sequences (T1-weighted, T2-weighted, and T1-enhanced).
- You must have had a PET/CT scan before starting any cancer treatment.
- If your MRI and PET/CT scans disagree on whether a lymph node has cancer, you must agree to have a needle biopsy of that lymph node.
- You cannot have had radiation therapy to the neck lymph nodes for any reason in the past.
- You cannot have any other type of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a deep learning computer model to look at tissue images and MRI scans to predict whether nasopharyngeal carcinoma may spread to other parts of the body. It may help doctors decide on the best treatment for people with certain stages of this cancer.
This study uses artificial intelligence to predict whether stomach cancer has spread to nearby lymph nodes. By analyzing your CT/MRI scans and biopsy results before surgery, the AI may help doctors plan your treatment more precisely.
This trial uses artificial intelligence to analyze digital images of tumor tissue to see if cancer has spread to nearby lymph nodes. It aims to improve diagnosis for many types of cancer.
This study tests whether an AI model can predict if cervical cancer has spread to lymph nodes as well as or better than standard imaging (MRI). If successful, it could help guide treatment decisions.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
This trial is testing a new artificial intelligence (AI) model to help doctors better identify whether gastric cancer has spread to nearby lymph nodes. If you qualify, you may help improve how this cancer is diagnosed and treated, without any extra invasive procedures.
Hear when a new Nasopharyngeal Cancinoma (NPC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.